GSI 150 (Viread 150 mg)

Generic Name: tenofovir

Pill imprint GSI 150 has been identified as Viread 150 mg.

Viread is used in the treatment of hepatitis b; hiv infection; nonoccupational exposure and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). There is no proven risk in humans during pregnancy. Viread 150 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for GSI 150

Viread
Generic Name:
tenofovir
Imprint:
GSI
150
Strength:
150 mg
Color:
White
Shape:
Three-sided
Availability:
Prescription only
Drug Class:
Nucleoside reverse transcriptase inhibitors (NRTIs)
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Gilead Sciences, Inc.
National Drug Code (NDC):
61958-0404
Inactive Ingredients:
corn starch
croscarmellose sodium
lactose monohydrate
microcrystalline cellulose
magnesium stearate
titanium dioxide
triacetin
hypromellose 2910 (15000 mPa.s)

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web5)